COX-2 Expression Predicts Worse Breast Cancer Prognosis and Does Not Modify the Association With Aspirin

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-011-1651-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Expression of Polycomb Targets Predicts Breast Cancer Prognosis

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2013English

Reduced Expression of FADS1 Predicts Worse Prognosis in Non-Small-Cell Lung Cancer

Journal of Cancer
Oncology
2016English

Association of GPIa and COX-2 Gene Polymorphism With Aspirin Resistance

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2017English

Does Nonmetastatic Inflammatory Breast Cancer Have a Worse Prognosis Than Other Nonmetastatic T4 Cancers?

Cancer
Cancer ResearchOncology
2018English

Expression of COX-2 and Steroid Converting Enzymes in Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2006English

Sleep Duration Does Not Mediate or Modify Association of Common Genetic Variants With Type 2 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2013English

Analysis of the Correlation Between P53 and Cox-2 Expression and Prognosis in Esophageal Cancer

Oncology Letters
Cancer ResearchOncology
2015English

The Low Expression of miR-451 Predicts a Worse Prognosis in Non-Small Cell Lung Cancer Cases

PLoS ONE
Multidisciplinary
2017English

HPV16 E7 Increases COX‑2 Expression and Promotes the Proliferation of Breast Cancer

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy